December 23, 2020 11:15 a.m.
WASHINGTON (AP) Pfizer said Wednesday it will supply the U.S. government with an additional 100 million doses of its COVID-19 vaccine under a new agreement between the pharmaceutical giant and the Trump administration.
Pfizer and its partner BioNTech said that will bring their total current commitment to 200 million doses for the U.S. That should be enough to vaccinate 100 million people with the two-shot regimen. The government also has an option to purchase an additional 400 million doses.
“This new federal purchase can give Americans even more confidence that we will have enough supply to vaccinate every American who wants it by June 2021,” said Health and Human Services Secretary Alex Azar in a statement. The cost to taxpayers: $1.95 billion for the additional 100 million doses.
The California Department of Public Health says the current ICU capacity in the Bay Area is 11.3%. There were 30,375 newly recorded confirmed cases in California on Friday.
Two weeks ago, each of the three major broadcast networks
ran with dubious reporting that claimed the United States was unable to obtain more of Pfizer’s coronavirus vaccine, because President Trump didn’t order enough. Disregarding the fact there was no way to know which vaccine would get approval first, they all leaped at the opportunity to bash Trump. But on Tuesday, there was new reporting that said Trump and Pfizer were nearing a deal to secure around 100 million more doses in time for summer.
It was great news that went completely unreported by
CBS Evening News, while ABC’s
COVID-19 deaths in U.S. see 2nd-highest spike; 195,000 new cases
By (0)
St. Louis Police Chief Colonel John W. Hayden Jr. hands out PPE packets to drivers at a charity event in St. Louis. Mo., last Saturday. Photo by Bill Greenblatt/UPI | License Photo
Dec. 23 (UPI) New COVID-19 cases in the United States are under 200,000 for the fourth straight day, but deaths nationwide have spiked, according to updated data from Johns Hopkins University on Wednesday.
The data show there were 195,000 new coronavirus cases nationally on Tuesday, but about 3,400 deaths the most since Dec. 16 and the second-highest daily toll to date.
Updated 12/23/2020 12:35 PM
WASHINGTON Pfizer said Wednesday it will supply the U.S. government with an additional 100 million doses of its COVID-19 vaccine under a new agreement between the pharmaceutical giant and the Trump administration.
Pfizer and its German partner BioNTech said that will bring their total current commitment to 200 million doses for the U.S. That should be enough to vaccinate 100 million people with the two-shot regimen. The government also has an option to purchase an additional 400 million doses.
This new federal purchase can give Americans even more confidence that we will have enough supply to vaccinate every American who wants it by June 2021, said Health and Human Services Secretary Alex Azar in a statement. The cost to taxpayers: $1.95 billion for the additional 100 million doses.